Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02889523
Title Study of Tazemetostat in Newly Diagnosed Diffuse Large B Cell and Follicular Lymphoma Patients Treated by Chemiotherapy (Epi-RCHOP)
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Lymphoma Academic Research Organisation
Indications

diffuse large B-cell lymphoma

follicular lymphoma

Therapies

Cyclophosphamide + Doxorubicin + Prednisolone + Rituximab + Tazemetostat + Vincristine Sulfate

Age Groups: senior | adult
Covered Countries FRA | BEL


No variant requirements are available.